Keyphrases
Clinical Outcomes
100%
AIDS/HIV
100%
Hodgkin Disease
100%
Radiotherapy
33%
Non-Hodgkin Lymphoma
33%
Overall Survival
25%
Progression-free Survival
25%
Human Immunodeficiency Virus Infection
25%
Event-free Survival
16%
Free Survival
16%
Histology
8%
Chemotherapy
8%
Disease Diagnosis
8%
Patient Demographics
8%
Treatment Regimen
8%
Survivors
8%
Treatment Outcome
8%
University of Texas
8%
Antiretroviral Therapy
8%
β2-microglobulin (β2-MG)
8%
Patient Survival
8%
Highly Active Antiretroviral Therapy (HAART)
8%
Clinical Characteristics
8%
CD4 Count
8%
Untreated Patients
8%
MD Anderson Cancer Center
8%
Disease Presentation
8%
Human Immunodeficiency Virus Negative
8%
Previously Untreated
8%
B Symptoms
8%
Serum Lactate Dehydrogenase
8%
Bone Marrow Involvement
8%
Mixed Cellularity
8%
Survival Events
8%
Extranodal Disease
8%
Low Serum Albumin
8%
Ann Arbor Staging
8%
Condition Diagnostics
8%
Nursing and Health Professions
Clinical Outcome
100%
Hodgkin Disease
100%
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
41%
Nonhodgkin Lymphoma
33%
Radiotherapy
33%
Progression Free Survival
25%
Human Immunodeficiency Virus Infection
25%
Overall Survival
25%
Diagnosis
16%
Event Free Survival
16%
CD4 Lymphocyte Count
8%
Cancer Center
8%
Treatment Outcome
8%
Patient Population
8%
Lactate Dehydrogenase Blood Level
8%
Patient Referral
8%
Infection
8%
Antiretroviral Therapy
8%
Highly Active Antiretroviral Therapy
8%
Disease
8%
Serum Albumin
8%
Medicine and Dentistry
Hodgkin's Lymphoma
100%
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
41%
Radiation Therapy
33%
Non-Hodgkin Lymphoma
33%
Overall Survival
25%
Progression Free Survival
25%
Human Immunodeficiency Virus Infection
25%
Diagnosis
16%
Event Free Survival
16%
Diseases
8%
Chemotherapy
8%
Patient Population
8%
Infection
8%
Malignant Neoplasm
8%
Antiretroviral Therapy
8%
Highly Active Antiretroviral Therapy
8%
ABVD
8%
Lactate Dehydrogenase
8%
Serum Albumin
8%
B Symptoms
8%
Patient Referral
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hodgkin Disease
100%
Acquired Immune Deficiency Syndrome
41%
Nonhodgkin Lymphoma
33%
Overall Survival
25%
Progression Free Survival
25%
Human Immunodeficiency Virus Infection
25%
Event Free Survival
16%
Chemotherapy
8%
Malignant Neoplasm
8%
Infection
8%
Disease
8%
Serum Albumin
8%
Lactate Dehydrogenase
8%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
71%
Human Immunodeficiency Virus Infection
42%
Overall Survival
42%
Progression Free Survival
42%
Event Free Survival
28%
CD4 Lymphocyte Count
14%
Lactate Dehydrogenase Blood Level
14%